Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Medtech
Live Remote Supervision of Neuroendovascular Surgery Enabled by Olympus MedPresence®
Life Sciences Times
-
February 11, 2021
0
Pharma
M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 17th Annual WORLDSymposium™ 2021
Life Sciences Times
-
February 11, 2021
0
Pharma
Drug Topics® Announces Partnership with inPharmacyJobs
Life Sciences Times
-
February 11, 2021
0
Real Estate
$205 Million in Financing for Life Sciences and Medical Office Building in Manhattan
Life Sciences Times
-
February 11, 2021
0
Venture Capital
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
Life Sciences Times
-
February 10, 2021
0
Biotech
Waters Redefines Laboratory Science with New ACQUITY PREMIER Liquid Chromatography Solution
Life Sciences Times
-
February 10, 2021
0
Public Health
AdvanCE, Powered by PTCE Offers COVID-19 Vaccination Program for Pharmacists and Technicians
Life Sciences Times
-
February 10, 2021
0
Real Estate
Pre-Built Labs Are Essential in Established and Emerging Life Sciences Markets
Life Sciences Times
-
February 10, 2021
0
Pharma
New Zealand approves 1st Covid-19 vaccine
Life Sciences Times
-
February 10, 2021
0
Public Health
UK variant of Covid strain reported in 86 countries: WHO
Life Sciences Times
-
February 10, 2021
0
1
...
779
780
781
...
805
Page 780 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026